Ondrey Aaron

Ondrey Aaron is listed in filings as Chief Financial Officer at Rocket Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jul 8, 2025, including sale activity. Recent filings connect the profile to Rocket Pharmaceuticals, Inc. (RCKT). The current snapshot covers public activity from Feb 13, 2025 to Jul 8, 2025. Reported amounts are shown as $1.3M to $4.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.